Our device uses an IV infusion instead of surgery to place a central line through an existing IV and obtain Central Venous Pressure (CVP) in minutes.   This product will be of particular interest to the person in charge of your hospital sepsis protocols and your emergency department because of fast evidence based data leading to earlier diagnosis .    Use our central line to validate the higher level DRGs and take advantage to the CPT reimbursements available for central lines placed BEFORE admission. Only ReavillMED can help in this way.   ReavilMED has a very modern medical device that opens up reimbursement CPT 93503 used in the Severe Sepsis Protocol.  The Surviving Sepsis Guidelines indicate that CVP should be measured accurately to complete the protocol.

ReavillMED’s business plan is a local use/local source design.  If a hospital Emergency Room is using the device, it will then be manufactured in the locality of the hospital.  If you investigate you will learn that almost everything a hospital uses is made elsewhere.  ReavillMED would like to change that and be a part of the fabric of the community it serves, like the hospitals.  The local sourcing is a part of its sustainability plan. We are really trying a new approach.
ReavillMED will employ over 10,000 persons across the country when fully rolled out; in New York it is anticipated that ReavillMED will employ 477 persons to start.  Each position is budgeted at $80,000.  It is also Matt Reavill’s plan to hire disabled veterans for these jobs and to add additional products.

According to information provided by the National Institutes for Health, the Centers for Disease Control and Prevention, and the Mayo Clinic, severe sepsis strikes approximately 750,000 Americans each year. Those with weakened immune systems, children, infants, and the elderly, are the most vulnerable. While early detection and aggressive treatment can improve the chances for survival, sepsis remains a leading cause of death in American hospitals. It is also an extremely costly condition; in 2008, nearly $15 billion was spent on hospitalizations for sepsis.

Between one-third and one-half of all sepsis patients die, and those who survive are more likely to have permanent organ damage, cognitive impairment, and physical disability. According to the New England Journal of Medicine, 10% of all ICU admissions are caused by sepsis, and the CDC notes that patients hospitalized for sepsis are more than eight times as likely to die during their hospitalization than those hospitalized for other diagnoses.